Search research articles

联系我们

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

隐私政策

政策

Search research articles

联系我们

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

隐私政策

政策

Search research articles

一个有毒性的惊喜.

G Brunner¹, R Zweiker, G J Krejs

¹Department of Internal Medicine, Karl-Franzens University, Graz, Austria. gernot.brunner@kfunigraz.ac.at

Lancet (London, England)

|October 29, 2000

概括

No abstract available in PubMed .

相关实验视频

一个有毒性的惊喜.

相关概念视频

Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance.

Massive fistulization into the left ventricle of a transplanted heart.

A nine-gene signature predicting clinical outcome in cutaneous melanoma.

GAB2 induces tumor angiogenesis in NRAS-driven melanoma.

Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management.

Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease.

相关实验视频

一个有毒性的惊喜.

相关概念视频

相关文章

Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance.

Massive fistulization into the left ventricle of a transplanted heart.

A nine-gene signature predicting clinical outcome in cutaneous melanoma.

GAB2 induces tumor angiogenesis in NRAS-driven melanoma.

Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management.

Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease.